Oragenics, Inc.
(NYSE Amex Equities : OGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.10%63.141.0%$460.56m
AMGNAmgen, Inc. 0.22%241.021.3%$449.50m
BIIBBiogen, Inc. 0.05%286.301.4%$389.27m
ILMNIllumina, Inc. -0.47%324.423.5%$319.00m
VRTXVertex Pharmaceuticals, Inc. -1.03%233.091.9%$297.02m
REGNRegeneron Pharmaceuticals, Inc. -0.47%383.772.6%$228.79m
EXASEXACT Sciences Corp. -0.45%89.3824.0%$203.47m
ALXNAlexion Pharmaceuticals, Inc. 1.43%114.122.0%$196.65m
ITCIIntra-Cellular Therapies, Inc. 1.01%26.909.0%$177.58m
INCYIncyte Corp. -0.23%80.442.5%$149.03m
SRPTSarepta Therapeutics, Inc. -1.47%128.3814.6%$143.00m
ARWRArrowhead Pharmaceuticals, Inc. -0.65%56.7411.4%$132.61m
SGENSeattle Genetics, Inc. 1.22%108.976.1%$126.96m
BMRNBioMarin Pharmaceutical, Inc. -0.73%88.484.3%$108.48m
AAgilent Technologies, Inc. 0.68%90.071.6%$106.43m

Company Profile

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.